RFA
TMO icon

Resurgent Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Resurgent Financial Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$423K Buy
861
+171
+25% +$92.8K 0.15% 159
2025
Q4 		$400K Buy
690
+66
+11% +$37.3K 0.2% 143
2025
Q3 		$303K Buy
624
+101
+19% +$47K 0.15% 168
2025
Q2 		$212K Buy
523
+4
+0.8% +$1.67K 0.12% 177
2025
Q1 		$258K Buy
519
+6
+1% +$3.25K 0.16% 151
2024
Q4 		$267K Sell
513
-3
-0.6% -$1.65K 0.16% 147
2024
Q3 		$319K Sell
516
-4
-0.8% -$2.37K 0.19% 138
2024
Q2 		$288K Buy
520
+51
+11% +$29.2K 0.18% 144
2024
Q1 		$273K Buy
469
+8
+2% +$4.49K 0.15% 154
2023
Q4 		$245K Buy
461
+120
+35% +$58.1K 0.15% 148
2023
Q3 		$173K Sell
341
-66
-16% -$35.2K 0.12% 164
2023
Q2 		$212K Buy
407
+5
+1% +$2.7K 0.14% 136
2023
Q1 		$232K Sell
402
-172
-30% -$96.9K 0.15% 131
2022
Q4 		$316K Sell
574
-10
-2% -$5.3K 0.17% 136
2022
Q3 		$296K Buy
584
+28
+5% +$15.7K 0.2% 138
2022
Q2 		$302K Buy
+556
New +$306K 0.19% 133

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Resurgent Financial Advisors's TMO Position: Q1 2026 in Review

Resurgent Financial Advisors increased its Thermo Fisher Scientific (TMO) stake by 25% in Q1 2026, buying an estimated $92.8K and bringing the position to 861 shares worth $423K. The position accounts for 0.15% of the portfolio, ranked #159.

Resurgent Financial Advisors first reported a position in TMO in Q2 2022 and has held it in 16 quarters since. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Resurgent Financial Advisors held 861 shares of Thermo Fisher Scientific worth $423K as of Q1 2026.
  • Resurgent Financial Advisors bought 171 Thermo Fisher Scientific shares in Q1 2026, an estimated $92.8K.
  • Thermo Fisher Scientific made up 0.15% of Resurgent Financial Advisors's portfolio in Q1 2026, its #159 holding.
  • Resurgent Financial Advisors first reported a position in Thermo Fisher Scientific in Q2 2022 and has held it in 16 quarters since.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Resurgent Financial Advisors's 13F filing for Q1 2026, filed 13 May 2026.